CTOs on the Move

FemTec Health

www.femtechealth.com

 
Founded in May 2020 by Dr. Kimon Angelides and publicly launched in October 2021, FemTec Health is the leading Health and Beauty Sciences Company focused on women`s health. Angelides has brought together a female-led team with decades of experience across healthcare, wellness, and consumer products in public and private companies. FemTec Health`s mission is to revolutionize women`s healthcare by using state-of-the-art genomics, predictive intelligence, and digital technologies to create an experience that is unified, coordinated, and provides personalized services and products that are meaningful and effective for women. With offices in Houston, New York, San Diego, London, Barcelona, Athens & ...
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

LUMEDX

LUMEDX is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oakland, CA. To find more information about LUMEDX, please visit www.lumedx.com

Satanta District Hospital

Satanta District Hospital provides a variety of services to citizens of Haskell County and surrounding communities, such as: outreach clinics from a variety of specialists, medical-surgical care, emergency services, surgical services, intermediate and

PeproTech

PeproTech is a Rocky Hill, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Masterson Group

The Masterson Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.